Persons with dispensed medicines; background and generation

Persons with dispensed medicines; background and generation

Sex Age Background and generation Medicine group (ATC) Periods Persons with medicines, relative (%)
Total male and female Total age Total background and generation C01D Vasodilators used in card. diseases 2020* 1.40
Total male and female Total age Total background and generation M05 Drugs for treatment of bone diseases 2020* 1.22
Total male and female Total age Total background and generation R03 Drugs for obstruct. airway diseases 2020* 8.20
Total male and female Total age Dutch background C01D Vasodilators used in card. diseases 2020* 1.52
Total male and female Total age Dutch background M05 Drugs for treatment of bone diseases 2020* 1.40
Total male and female Total age Dutch background R03 Drugs for obstruct. airway diseases 2020* 8.59
Total male and female Total age With migration background C01D Vasodilators used in card. diseases 2020* 1.04
Total male and female Total age With migration background M05 Drugs for treatment of bone diseases 2020* 0.70
Total male and female Total age With migration background R03 Drugs for obstruct. airway diseases 2020* 7.04
Total male and female Total age 1st generation migration background C01D Vasodilators used in card. diseases 2020* 1.29
Total male and female Total age 1st generation migration background M05 Drugs for treatment of bone diseases 2020* 0.79
Total male and female Total age 1st generation migration background R03 Drugs for obstruct. airway diseases 2020* 6.51
Total male and female Total age 2nd generation migration background C01D Vasodilators used in card. diseases 2020* 0.74
Total male and female Total age 2nd generation migration background M05 Drugs for treatment of bone diseases 2020* 0.59
Total male and female Total age 2nd generation migration background R03 Drugs for obstruct. airway diseases 2020* 7.67
Total male and female Total age Western migration background C01D Vasodilators used in card. diseases 2020* 1.26
Total male and female Total age Western migration background M05 Drugs for treatment of bone diseases 2020* 0.99
Total male and female Total age Western migration background R03 Drugs for obstruct. airway diseases 2020* 6.91
Total male and female Total age Non-western migration background C01D Vasodilators used in card. diseases 2020* 0.87
Total male and female Total age Non-western migration background M05 Drugs for treatment of bone diseases 2020* 0.48
Total male and female Total age Non-western migration background R03 Drugs for obstruct. airway diseases 2020* 7.14
Total male and female Total age Morocco C01D Vasodilators used in card. diseases 2020* 0.66
Total male and female Total age Morocco M05 Drugs for treatment of bone diseases 2020* 0.47
Total male and female Total age Morocco R03 Drugs for obstruct. airway diseases 2020* 8.48
Total male and female Total age Turkey C01D Vasodilators used in card. diseases 2020* 1.34
Total male and female Total age Turkey M05 Drugs for treatment of bone diseases 2020* 0.62
Total male and female Total age Turkey R03 Drugs for obstruct. airway diseases 2020* 8.37
Total male and female Total age Surinam C01D Vasodilators used in card. diseases 2020* 1.77
Total male and female Total age Surinam M05 Drugs for treatment of bone diseases 2020* 0.66
Total male and female Total age Surinam R03 Drugs for obstruct. airway diseases 2020* 9.76
Total male and female Total age (former) Net Antilles, Aruba C01D Vasodilators used in card. diseases 2020* 0.61
Total male and female Total age (former) Net Antilles, Aruba M05 Drugs for treatment of bone diseases 2020* 0.37
Total male and female Total age (former) Net Antilles, Aruba R03 Drugs for obstruct. airway diseases 2020* 7.86
Total male and female Total age Other non-western background C01D Vasodilators used in card. diseases 2020* 0.52
Total male and female Total age Other non-western background M05 Drugs for treatment of bone diseases 2020* 0.38
Total male and female Total age Other non-western background R03 Drugs for obstruct. airway diseases 2020* 5.20
Total male and female 0 to 14 years Total background and generation C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years Total background and generation M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years Total background and generation R03 Drugs for obstruct. airway diseases 2020* 5.42
Total male and female 0 to 14 years Dutch background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years Dutch background M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years Dutch background R03 Drugs for obstruct. airway diseases 2020* 5.40
Total male and female 0 to 14 years With migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years With migration background M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years With migration background R03 Drugs for obstruct. airway diseases 2020* 5.48
Total male and female 0 to 14 years 1st generation migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years 1st generation migration background M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years 1st generation migration background R03 Drugs for obstruct. airway diseases 2020* 3.00
Total male and female 0 to 14 years 2nd generation migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years 2nd generation migration background M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years 2nd generation migration background R03 Drugs for obstruct. airway diseases 2020* 6.06
Total male and female 0 to 14 years Western migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years Western migration background M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years Western migration background R03 Drugs for obstruct. airway diseases 2020* 4.59
Total male and female 0 to 14 years Non-western migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years Non-western migration background M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years Non-western migration background R03 Drugs for obstruct. airway diseases 2020* 5.92
Total male and female 0 to 14 years Morocco C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years Morocco M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years Morocco R03 Drugs for obstruct. airway diseases 2020* 7.52
Total male and female 0 to 14 years Turkey C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years Turkey M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years Turkey R03 Drugs for obstruct. airway diseases 2020* 5.84
Total male and female 0 to 14 years Surinam C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years Surinam M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years Surinam R03 Drugs for obstruct. airway diseases 2020* 6.99
Total male and female 0 to 14 years (former) Net Antilles, Aruba C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years (former) Net Antilles, Aruba M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years (former) Net Antilles, Aruba R03 Drugs for obstruct. airway diseases 2020* 8.06
Total male and female 0 to 14 years Other non-western background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 0 to 14 years Other non-western background M05 Drugs for treatment of bone diseases 2020* 0.00
Total male and female 0 to 14 years Other non-western background R03 Drugs for obstruct. airway diseases 2020* 4.90
Total male and female 15 to 24 years Total background and generation C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years Total background and generation M05 Drugs for treatment of bone diseases 2020* 0.02
Total male and female 15 to 24 years Total background and generation R03 Drugs for obstruct. airway diseases 2020* 4.35
Total male and female 15 to 24 years Dutch background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years Dutch background M05 Drugs for treatment of bone diseases 2020* 0.02
Total male and female 15 to 24 years Dutch background R03 Drugs for obstruct. airway diseases 2020* 4.60
Total male and female 15 to 24 years With migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years With migration background M05 Drugs for treatment of bone diseases 2020* 0.02
Total male and female 15 to 24 years With migration background R03 Drugs for obstruct. airway diseases 2020* 3.74
Total male and female 15 to 24 years 1st generation migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years 1st generation migration background M05 Drugs for treatment of bone diseases 2020* 0.01
Total male and female 15 to 24 years 1st generation migration background R03 Drugs for obstruct. airway diseases 2020* 1.51
Total male and female 15 to 24 years 2nd generation migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years 2nd generation migration background M05 Drugs for treatment of bone diseases 2020* 0.02
Total male and female 15 to 24 years 2nd generation migration background R03 Drugs for obstruct. airway diseases 2020* 5.23
Total male and female 15 to 24 years Western migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years Western migration background M05 Drugs for treatment of bone diseases 2020* 0.01
Total male and female 15 to 24 years Western migration background R03 Drugs for obstruct. airway diseases 2020* 2.62
Total male and female 15 to 24 years Non-western migration background C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years Non-western migration background M05 Drugs for treatment of bone diseases 2020* 0.02
Total male and female 15 to 24 years Non-western migration background R03 Drugs for obstruct. airway diseases 2020* 4.41
Total male and female 15 to 24 years Morocco C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years Morocco M05 Drugs for treatment of bone diseases 2020* 0.02
Total male and female 15 to 24 years Morocco R03 Drugs for obstruct. airway diseases 2020* 6.15
Total male and female 15 to 24 years Turkey C01D Vasodilators used in card. diseases 2020* 0.00
Total male and female 15 to 24 years Turkey M05 Drugs for treatment of bone diseases 2020* 0.02
Total male and female 15 to 24 years Turkey R03 Drugs for obstruct. airway diseases 2020* 3.96
Total male and female 15 to 24 years Surinam C01D Vasodilators used in card. diseases 2020* 0.01
Source: CBS.
Explanation of symbols

Table description


This table contains figures on the absolute number of persons to whom in the year concerned medicines were dispensed for which the costs are reimbursed under the statutory basic medical insurance. The figures are also expressed as a percentage of the total population in the category concerned. The population includes everybody registered in the Basic Registration of Persons (BRP) and living in the Netherlands at some point in the year concerned. Until 2010 the figures also included medicines dispensed to persons registered in the BRP, but no longer resident in the Netherlands.
Medicines provided to persons in hospitals and nursing homes are not included; medicines provided in residential homes for the elderly are included.

Data are broken down by medicine group, background, generation, age and sex.

Data available from: 2006

Status of the figures:
Figures for 2020 are provisional. Remaining figures are definite.

Changes as of 10 December, 2021:
Figures for 2019 have been made final and provisional figures for 2020 have been added.

When will new figures be published?
New figures will be published in the last quarter of 2022.

Description topics

Persons with medicines, relative
Number of persons to whom medicines are dispensed in the year concerned that are reimbursed under the statutory basic medical insurance, expressed as a percentage of the total population of the category concerned registered in the Basic Registration of Persons (BRP) in that year.